Prospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 28, 2022; 28(32): 4716-4725
Published online Aug 28, 2022. doi: 10.3748/wjg.v28.i32.4716
Table 1 Differences in age, gender and history of malignancy between malignant and benign groups

Age (yr)
Gender
History of malignancy
Male
Female
Yes
No
Malignant (n = 96)44.68 ± 12.3073231185
Benign (n = 31)57.31 ± 10.36724130
t/χ25.63328.7291.856
P value0.0000.0000.291
Table 2 Differences in age, gender and history of malignancy among three types of malignancy

Age (yr)
Gender
History of malignancy
Male
Female
Yes
No
CCCs (n = 16)58.63 ± 10.37115115
HCCs (n = 69)56.07 ± 10.51a5415564
Liver metastasis (n = 11)63.18 ± 7.558356
F/χ22.4600.72014.165
P value0.0910.6980.001
Table 3 Differences in two-dimensional shear wave elastography results between benign and malignant focal liver lesions

Emax of tumors (m/s)
Emax of periphery of tumors (m/s)
Malignant (n = 100)2.21 ± 0.571.52 ± 0.39
Benign (n = 32)1.59 ± 0.371.36 ± 0.44
t5.7812.073
P value0.0000.040
Table 4 Differences of two-dimensional shear wave elastography results among different types of malignant focal liver lesions

Emax of the tumors (m/s)
Emax of the periphery of tumors (m/s)
CCCs (n = 16)2.14 ± 0.34a1.56 ± 0.39
HCCs (n = 72)2.14 ± 0.46b1.54 ± 0.37
Liver metastases (n = 12)2.73 ± 0.991.36 ± 0.46
F6.4181.299
P value0.0020.277